BACKGROUND: The etiopathogenesis of atopic dermatitis is complicated, and it includes aspects such as dysfunction of the skin barrier, changes in immune responses, IgE-mediated hypersensitivity, and many characteristics of the environment. Regarding skin barrier dysfunction, a number of genetic changes have been described. This genetic predisposition could be related to the phenotypes of atopic dermatitis. AIM: In this study, several polymorphisms in five proinflammatory genes were associated with certain phenotypes of AD patients (genotype-phenotype study). METHODS: In total, 89 unrelated AD Czech (Caucasian) patients were genotyped regarding five proinflammatory gene polymorphisms (angiotensinogen AGT M235T, AGT-6 G/A, TNF-α-238 G/A, TNF-β Fok1, IL-6-174 C/G and IL-6-596 G/A). Genotyping was performed using PCR and restriction analysis. For phenotypes, patients' sex, age and personal and family history of atopy, aero- and food allergies and other complex diseases were evaluated. RESULTS: A significant association with transepidermal water loss (TEWL) measured on the forearm was found with the AGT M235T polymorphism (p = 0.02). For the AG genotype of TNF-α-238 G/A, a six-times higher risk for a family history of diabetes mellitus compared to other examined aspects of family history was found (p = 0.02). A family history of thyreopathy was associated with the IL-6-174 G/C polymorphism when compared to a family history of other complex diseases. The GG genotype had a ten-times higher risk for a family history of thyreopathy compared to the other genotypes (p = 0.004). This result was highly specific (0.914). The GG genotype of IL-6-596 G/A was associated with a family history of thyreopathy, with the same result (p = 0.004). Moreover, the G allele of IL-6-174 G/C was associated with a family history of thyreopathy compared to AD patients without a positive family history of complex diseases (p = 0.03). In AD men, the MM genotype of the AGT M235T gene was found to be associated with food allergies (p = 0.004). This result was highly sensitive (0.833). A family history of cardiovascular disease in AD men was associated with AGT-6 G/A variability. The A allele was found to be six times more frequent in patients with a positive family history of cardiovascular disease (p = 0.02, with high sensitivity and specificity (0.700 and 0.735, respectively)). A family history of diabetes mellitus was associated with the TNF-β Fok1 polymorphism, where the B1 allele was almost six times more frequent in AD men with a positive family history of diabetes mellitus (p = 0.02), with high sensitivity (0.85). A significant association between TEWL measured on the forearm and the AGT M235T polymorphism was found when AD women were carriers of the MM genotype, with a median of 25 and range 4-61; those patients with the MT genotype had a median of 10 and range of 0.3-39; and patients with the TT genotype had a median of 5 and range of 3-40, p = 0.003. The polymorphism AGT-6 G/A was associated with different ages of eczema onset. The AG genotype was almost nine times more risky for the youngest group (0-7 years) compared to the oldest group (more than 18 years) (p = 0.02), with high specificity for this result. CONCLUSIONS: Our results in the field of cytokine signaling in the immune system in patients with atopic dermatitis are in agreement with those of GWASs. We suggest that cost-effective and simple PCR tests may be the best approach for the rapid and optimal collection of valid genetic information in clinical practice.

1st Department of Dermatology St Ann's Faculty Hospital Faculty of Medicine Masaryk University 60200 Brno Czech Republic

Department of Pathophysiology Faculty of Medicine Masaryk University 62500 Brno Czech Republic

Zobrazit více v PubMed

Afshari M., Kolackova M., Rosecka M., Čelakovská J., Krejsek J. Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches. Front. Immunol. 2024;15:1361005. doi: 10.3389/fimmu.2024.1361005. PubMed DOI PMC

Bantz S.K., Zhu Z., Zheng T. The atopic march: Progression from atopic dermatitis to allergic rhinitis and asthma. J. Clin. Cell Immunol. 2014;5:2. PubMed PMC

Wang V., Boguniewicz J., Boguniewicz M., Ong P.Y. The infectious complications of atopic dermatitis. Ann. Allergy Asthma Immunol. 2021;126:3–12. doi: 10.1016/j.anai.2020.08.002. PubMed DOI PMC

Weidinger S., Beck L.A., Bieber T., Kabashima K., Irvine A.D. Atopic dermatitis. Nat. Rev. Dis. Primers. 2018;4:1. doi: 10.1038/s41572-018-0001-z. PubMed DOI

von Kobyletzki L.B., Bornehag C.G., Breeze E., Larsson M., Lindstrom C.B., Svensson A. Factors associated with remission of eczema in children: A population-based follow-up study. Acta Derm. Venereol. 2014;94:179–184. doi: 10.2340/00015555-1681. PubMed DOI

Higgins J., Thompson S., Deeks J., Altman D. Statistical heterogeneity in systematic reviews of clinical trials: A critical appraisal of guidelines and practice. J. Health Serv. Res. Policy. 2002;7:51–61. doi: 10.1258/1355819021927674. PubMed DOI

Bylund S., Kobyletzki L.B., Svalstedt M., Svensson Å. Prevalence and Incidence of Atopic Dermatitis: A Systematic Review. Acta Derm. Venereol. 2020;100:adv00160. doi: 10.2340/00015555-3510. PubMed DOI PMC

LeBovidge J.S., Schneider L.C. Depression and anxiety in patients with atopic dermatitis: Recognizing and addressing mental health burden. Ann. Allergy Asthma Immunol. 2025;134:506–515. doi: 10.1016/j.anai.2025.02.017. PubMed DOI

Holmes A., Marella P., Rodriguez C., Glass Ii D., Goerlich K.S. Alexithymia and Cutaneous Disease Morbidity: A Systematic Review. Dermatology. 2022;238:1120–1129. doi: 10.1159/000524736. PubMed DOI

Chiricozzi A., Esposito M., Gisondi P., Valenti M., Gori N., Giovanardi G., Bellinato F., De Simone C., Costanzo A., Fargnoli M.C., et al. Disease Severity Is Associated with Alexithymia in Patients with Atopic Dermatitis. Dermatology. 2020;236:329–335. doi: 10.1159/000507246. PubMed DOI

Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat. Immunol. 2010;11:73–84. doi: 10.1038/ni.1863. PubMed DOI

Manicassamy S., Pulendran B. Modulation of adaptive immunity with Toll-like receptors. Semin. Immunol. 2009;21:185–193. doi: 10.1016/j.smim.2009.05.005. PubMed DOI PMC

Danso M.O., van Drongelen V., Mulder A., van Esch J., Scott H., van Smeden J., El Ghalbzouri A., Bouwstra J.A. TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents. J. Investig. Dermatol. 2014;134:1941–1950. doi: 10.1038/jid.2014.83. PubMed DOI

Zhang L.J., Guerrero-Juarez C.F., Hata T., Bapat S.P., Ramos R., Plikus M.V., Gallo R.L. Innate immunity. Dermal adipocytes protect against invasive Staphylococcus aureus skin infection. Science. 2015;347:67–71. doi: 10.1126/science.1260972. PubMed DOI PMC

Lai Y., Gallo R.L. Toll-like receptors in skin infections and inflammatory diseases. Infect. Disord. Drug Targets. 2008;8:144–155. doi: 10.2174/1871526510808030144. PubMed DOI PMC

Pedullá M., Fierro V., Papacciuolo V., Alfano R., Ruocco E. Atopy as a risk factor for thyroid autoimmunity in children affected with atopic dermatitis. J. Eur. Acad. Dermatol. Venereol. 2014;8:1057–1060. doi: 10.1111/jdv.12281. PubMed DOI

Zhang C., Hong C., Lian X., Wen L., Xu K., Tian Z., Si W., Li Y. Correlations of thyroid autoantibodies with allergic diseases: A case-control study of 434 Chinese patients. Medicine. 2022;101:e29871. doi: 10.1097/MD.0000000000029871. PubMed DOI PMC

Rondinone C.M. Adipocyte-derived hormones, cytokines, and mediators. Endocrine. 2006;1:81–90. doi: 10.1385/ENDO:29:1:81. PubMed DOI

Ahima R.S., Flier J.S. Adipose tissue as an endocrine organ. Trends Endocrinol. Metab. 2000;11:327–332. doi: 10.1016/S1043-2760(00)00301-5. PubMed DOI

Fried S.K., Bunkin D.A., Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid. J. Clin. Endocrinol. Metab. 1998;83:847–850. doi: 10.1210/jc.83.3.847. PubMed DOI

Hermsdorff H.H., Zulet M.A., Puchau B., Martinez J.A. Central adiposity rather than total adiposity measurements are specifically involved in the inflammatory status from healthy young adults. Inflammation. 2011;34:161–170. doi: 10.1007/s10753-010-9219-y. PubMed DOI

Lapice E., Maione S., Patti L., Cipriano P., Rivellese A.A., Riccardi G., Vaccaro O. Abdominal adiposity is associated with elevated C-reactive protein independent of BMI in healthy non-obese people. Diabetes Care. 2009;32:1734–1736. doi: 10.2337/dc09-0176. PubMed DOI PMC

Spinarová L., Spinar J., Vasků A., Pávková- Goldbergová M., Ludka O., Tomandl J., Vítovec J. Genetics of humoral and cytokine activation in heart failure and its importance for risk stratification of patients. Exp. Mol. Pathol. 2008;84:251–255. doi: 10.1016/j.yexmp.2008.03.002. PubMed DOI

Goldbergova M., Spinarova L., Spinar J., Toman J., Vasku A., Vacha J. Association of two angiotensinogen gene polymorphisms, M235T and G(-6)A, with chronic heart failure. Int. J. Cardiol. 2003;89:267–272. doi: 10.1016/S0167-5273(02)00506-5. PubMed DOI

Pasanen A., Sliz E., Huilaja L., FinnGen. Estonian Biobank Research Team. Reimann E., Mägi R., Laisk T., Tasanen K., Kettunen J. Identifying Atopic Dermatitis Risk Loci in 1,094,060 Individuals with Subanalysis of Disease Severity and Onset. J. Investig. Dermatol. 2024;144:2417–2425. doi: 10.1016/j.jid.2024.02.036. PubMed DOI

Løset M., Brown S.J., Saunes M., Hveem K. Genetics of atopic dermatitis: From DNA sequence to clinical relevance. Dermatology. 2019;235:355e64. doi: 10.1159/000500402. PubMed DOI

Brown S.J. What have we learned from GWAS for atopic dermatitis? J. Investig. Dermatol. 2021;141:19e22. doi: 10.1016/j.jid.2020.05.100. PubMed DOI

Budu-Aggrey A., Kilanowski A., Sobczyk M.K., 23andMe Research Team. Shringarpure S.S., Mitchell R., Reis K., Reigo A., Estonian Biobank Research Team. Mägi R., et al. European and multi-ancestry genome-wide association meta-analysis of atopic dermatitis highlights importance of systemic immune regulation. Nat. Commun. 2023;14:6172. doi: 10.1038/s41467-023-41180-2. PubMed DOI PMC

Paternoster L., Standl M., Waage J., Baurecht H., Hotze M., Strachan D.P., Curtin J.A., Bønnelykke K., Tian C., Takahashi A., et al. Multi-ancestry genome-wide association study of 21,000 cases and 95,000 controls identifies new risk loci for atopic dermatitis. Nat. Genet. 2015;47:1449–1456. PubMed PMC

Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., Goudie D.R., Sandilands A., Campbell L.E., Smith F.J., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 2006;38:441–446. doi: 10.1038/ng1767. PubMed DOI

Liang Y., Chang C., Lu Q. The genetics and epigenetics of atopic dermatitis f ilaggrin and other polymorphisms. Clin. Rev. Allergy Immunol. 2016;51:315e28. doi: 10.1007/s12016-015-8508-5. PubMed DOI

Sliz E., Huilaja L., Pasanen A., Laisk T., Reimann E., Mägi R., FinnGen. Estonian Biobank Research Team. Hannula-Jouppi K., Peltonen S., et al. Uniting biobank resources reveals novel genetic pathways modulating susceptibility for atopic dermatitis. J. Allergy Clin. Immunol. 2022;149:1105–1112.e9. doi: 10.1016/j.jaci.2021.07.043. PubMed DOI

Kim J., Kim B.E., Leung D.Y.M. Pathophysiology of atopic dermatitis: Clinical implications. Allergy Asthma Proc. 2019;40:84–92. doi: 10.2500/aap.2019.40.4202. PubMed DOI PMC

Chen R.H., Chang C.T., Chen W.C., Tsai C.H., Tsai F.J. Proinflammatory cytokine gene polymorphisms among Hashimoto’s thyroiditis patients. J. Clin. Lab. Anal. 2006;20:260–265. doi: 10.1002/jcla.20152. PubMed DOI PMC

Winget J.M., Finlay D., Mills K.J., Huggins T., Bascom C., Isfort R.J., Moritz R.L. Quantitative Proteomic Analysis of Stratum Corneum Dysfunction in Adult Chronic Atopic Dermatitis. J. Investig. Dermatol. 2016;136:1732–1735. doi: 10.1016/j.jid.2016.03.037. PubMed DOI PMC

Arehart C.H., Daya M., Campbell M., Boorgula M.P., Rafaels N., Chavan S., David G., Hanifin J., Slifka M.K., Gallo R.L., et al. Polygenic prediction of atopic dermatitis improves with atopic training and filaggrin factors. J. Allergy Clin. Immunol. 2022;149:145–155. doi: 10.1016/j.jaci.2021.05.034. PubMed DOI PMC